Pharma Stocks Outlook
Stocks to maintain healthy growth after US-China deal
This story was originally published at 18:37 IST on 13 June 2025
Register to read our real-time news.Informist, Friday, Jun. 13, 2025
MUMBAI – Shares of pharmaceutical companies are likely to extend gains accumulated this week as optimism in the market grew after several trade-related conflicts recently cooled down. Trade tensions between the US and China have eased after top officials of both countries met in London and agreed upon a preliminary plan to lift trade restrictions. This move might be beneficial for Indian pharmaceutical companies as they depend on China for 70-80% of active pharmaceutical ingredient imports, said an analyst from a domestic brokerage firm.
"Indian pharma companies were badly hit during the trade tensions that escalated after the US imposed reciprocal tariffs. Now that many countries are trying to reach a deal with the US, growth in pharma sector can be clearly seen and this will continue in the short term," another analyst from a brokerage said. He added that many stocks are performing well due an increase in domestic sales of the Indian pharmaceutical firms.
The Nifty Pharma closed slightly down Friday but still gained over 1% during this week. The sectoral index closed at 21985.15 points. Biocon was the biggest gainer and rose nearly 8% this week, followed by Natco Pharma, which gained over 6%. Shares of Granules India were the worst hit and fell nearly 4% this week.
According to a research report by Choice Broking Wednesday, the biosimilars space continues to evolve rapidly, supported by upcoming patent expiries, robust pipelines and strategic collaborations. Despite a majority of companies facing a slight downfall in the US sales, it still remains a key growth market with companies such as Cipla preparing for new launches in the US, the brokerage said.
Ajanta Pharma and Apollo Hospitals Enterprises are Choice Broking's top picks. It has 'buy' ratings on Ajanta Pharma with a target price of INR 3,180 and Apollo Enterprises with a target price of INR 8,000.
TOP HEADLINES
* CNBC-TV18: Bhartias to sell shrs in three Jubilant group cos via block deals
* Jubilant Pharmova transfers bulk drug operations to arm Jubilant Biosys
* HC refuses to bar Sun Pharma, arm from selling Pruease in infringement plea
* Samprada & Nanhamati Singh Family Trust sells 0.6% stake in Alkem Lab
* US FDA tags 'no action indicated' to Zydus Life's Ankleshwar API mfg unit
* Zydus Life says US FDA audit at Dabhasa closed with voluntary action tag
* NCLT approves Asons Pharma's resolution plan for Astral Steritech
* AstraZeneca Pharma appoints Praveen Akkinepally as MD effective Jul 1
* Glenmark to launch cancer treatment drug Brukinsa in India
* Lupin gets US FDA nod for generic of Oxtellar XR extended-release tablets
Following are the resistance and support levels for the stocks for next week as per calculations by Informist based on their prices on the National Stock Exchange:
| Company | Price | Week-on-Week Change in % | Resistance | Support |
| Abbott India | 31515.00 | (-)0.40 | 31938.30 | 30888.30 |
| Alkem Laboratories | 4847.50 | (-)0.30 | 4926.80 | 4703.80 |
| Aurobindo Pharma | 1150.20 | (-)0.90 | 1166.30 | 1127.50 |
| Biocon | 355.40 | 7.70 | 365.70 | 339.90 |
| Cipla | 1505.20 | 0.10 | 1529.10 | 1468.10 |
| Divi's Laboratories | 6667.00 | 1.90 | 6775.70 | 6556.70 |
| Dr. Reddy's Laboratories | 1362.50 | 3.20 | 1379.90 | 1336.30 |
| Gland Pharma | 1689.70 | 2.90 | 1736.00 | 1606.80 |
| GlaxoSmithKline Pharmaceuticals | 3295.00 | (-)4.20 | 3368.10 | 3222.10 |
| Glenmark Pharmaceuticals | 1669.90 | 5.00 | 1718.60 | 1580.60 |
| Granules India | 509.40 | (-)3.90 | 529.60 | 498.00 |
| Ipca Laboratories | 1368.40 | (-)0.20 | 1392.90 | 1340.90 |
| Laurus Labs | 666.60 | 3.80 | 687.30 | 639.80 |
| Lupin | 1999.60 | 0.00 | 2038.50 | 1960.50 |
| Natco Pharma | 912.70 | 6.30 | 942.10 | 876.00 |
| Pfizer | 5882.50 | 3.10 | 6007.50 | 5722.50 |
| Sanofi India | 6147.50 | 0.00 | 6281.20 | 6023.20 |
| Sun Pharmaceutical Industries | 1687.80 | 0.50 | 1721.90 | 1644.10 |
| Torrent Pharmaceuticals | 3252.50 | 3.10 | 3312.80 | 3144.80 |
| Zydus Lifesciences | 974.95 | 1.50 | 988.60 | 953.20 |
| Nifty Pharma | 21985.15 | 1.40 | 22178.90 | 21645.20 |
| Nifty 50 | 24718.60 | (-)1.10 | 24930.00 | 24367.30 |
| S&P Bse Sensex | 81118.60 | (-)1.30 | 81788.00 | 80019.90 |
End
Reported by P. Madhu Kumar
Edited by Deepshikha Bhardwaj
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2025. All rights reserved.
To read more please subscribe
Share this Story:
